InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Chang Michael L., Directeur Médical. Director active across 2 companies, notably Nutex Health, Inc.. In total, 3 reports have been logged. Activity tracked since 1 March 2025. The latest transaction was filed on 10 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Michael L. Chang is the Chief Medical Officer at Nutex Health, Inc. In this role, he is responsible for the medical strategy and innovation within the company. Chang plays a key role in developing health solutions aimed at improving patient care.